Candida glabrata endophthalmitis treated successfully with caspofungin.

Juan Sarria, Jay C. Bradley, Ranya Habash, Kelly T. Mitchell, Robert C. Kimbrough, Ana M. Vidal

Research output: Contribution to journalArticle

58 Citations (Scopus)

Abstract

A 39-year-old man with Candida glabrata endophthalmitis was successfully treated with a 28-day course of intravenous caspofungin. Presence of underlying renal insufficiency and infection with a drug-resistant strain precluded use of amphotericin B or fluconazole. Intravitreal administration of antifungals and vitrectomy were not required. The role of caspofungin in Candida endophthalmitis is discussed.

Original languageEnglish (US)
JournalClinical infectious diseases : an official publication of the Infectious Diseases Society of America
Volume40
Issue number5
StatePublished - 2005

Fingerprint

caspofungin
Candida glabrata
Endophthalmitis
Fluconazole
Vitrectomy
Amphotericin B
Candida
Renal Insufficiency
Infection
Pharmaceutical Preparations

Cite this

Candida glabrata endophthalmitis treated successfully with caspofungin. / Sarria, Juan; Bradley, Jay C.; Habash, Ranya; Mitchell, Kelly T.; Kimbrough, Robert C.; Vidal, Ana M.

In: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, Vol. 40, No. 5, 2005.

Research output: Contribution to journalArticle

Sarria, Juan ; Bradley, Jay C. ; Habash, Ranya ; Mitchell, Kelly T. ; Kimbrough, Robert C. ; Vidal, Ana M. / Candida glabrata endophthalmitis treated successfully with caspofungin. In: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2005 ; Vol. 40, No. 5.
@article{040103126d6d4f8a887a93b2552df825,
title = "Candida glabrata endophthalmitis treated successfully with caspofungin.",
abstract = "A 39-year-old man with Candida glabrata endophthalmitis was successfully treated with a 28-day course of intravenous caspofungin. Presence of underlying renal insufficiency and infection with a drug-resistant strain precluded use of amphotericin B or fluconazole. Intravitreal administration of antifungals and vitrectomy were not required. The role of caspofungin in Candida endophthalmitis is discussed.",
author = "Juan Sarria and Bradley, {Jay C.} and Ranya Habash and Mitchell, {Kelly T.} and Kimbrough, {Robert C.} and Vidal, {Ana M.}",
year = "2005",
language = "English (US)",
volume = "40",
journal = "Clinical Infectious Diseases",
issn = "1058-4838",
publisher = "Oxford University Press",
number = "5",

}

TY - JOUR

T1 - Candida glabrata endophthalmitis treated successfully with caspofungin.

AU - Sarria, Juan

AU - Bradley, Jay C.

AU - Habash, Ranya

AU - Mitchell, Kelly T.

AU - Kimbrough, Robert C.

AU - Vidal, Ana M.

PY - 2005

Y1 - 2005

N2 - A 39-year-old man with Candida glabrata endophthalmitis was successfully treated with a 28-day course of intravenous caspofungin. Presence of underlying renal insufficiency and infection with a drug-resistant strain precluded use of amphotericin B or fluconazole. Intravitreal administration of antifungals and vitrectomy were not required. The role of caspofungin in Candida endophthalmitis is discussed.

AB - A 39-year-old man with Candida glabrata endophthalmitis was successfully treated with a 28-day course of intravenous caspofungin. Presence of underlying renal insufficiency and infection with a drug-resistant strain precluded use of amphotericin B or fluconazole. Intravitreal administration of antifungals and vitrectomy were not required. The role of caspofungin in Candida endophthalmitis is discussed.

UR - http://www.scopus.com/inward/record.url?scp=33644892911&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33644892911&partnerID=8YFLogxK

M3 - Article

VL - 40

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

SN - 1058-4838

IS - 5

ER -